remdesivir | Page 2 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
August 23, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, AUGUST 23, 2025

remdesivir

Remdesivir pushes up Beacon Pharma’s profit  
Pharma

Remdesivir pushes up Beacon Pharma’s profit  

At the end of the first half of this fiscal year, the company’s earnings per share stood at Tk1.26.

antiviral drug Remdesivir. Photo : BSS/AFP
Coronavirus chronicle

Single-patient study adds to debate over Gilead's remdesivir for Covid-19

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

US infectious disease group backs Gilead's remdesivir for Covid-19 treatment

Hasty drug approval doesn’t always work out. Photographer: OLIVIER DOULIERY/AFP via Getty Images/Bloomberg
Analysis

Remdesivir’s failure is a warning for Covid-19 vaccines

Photo: Collected.
Coronavirus chronicle

Remdesivir: Don't use drug Trump took for Covid-19, WHO says

WHO says it will have advice on Remdesivir in 3-4 weeks
Coronavirus chronicle

WHO says it will have advice on Remdesivir in 3-4 weeks

antiviral drug Remdesivir. Photo : BSS/AFP
Coronavirus chronicle

US gives full approval to antiviral remdesivir to treat Covid-19

Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (Covid-19), during the outbreak of the coronavirus disease (Covid-19), in Oceanside, California, US, April 29, 2020. Photo: Reuters
Coronavirus chronicle

Remdesivir has ‘little effect’ on Covid-19 death risks, WHO study says

European Union flags fly outside the EU Commission headquarters in Brussels, Belgium September 19, 2019/ Reuters
Coronavirus chronicle

EU signs joint procurement contract for remdesivir supply

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

Europe in remdesivir crisis

President Donald Trump wears a mask as he tours the American Red Cross national headquarters in Washington on July 30.Doug Mills / The New York Times via AP pool
Coronavirus chronicle

What medicines Trump is given for Covid-19 treatment

Photo: Collected.
Coronavirus chronicle

Beximco Pharma, IFIC Bank, Nepal Bangladesh Bank donate Remdesivir to Nepal

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters
Coronavirus chronicle

India's shortage of remdesivir is easing, says producer Cipla

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net